Cargando…

CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma

C-C motif chemokine ligand 14 (CCL14) is a chemokine promoting the activation of immune cells. However, the relationship between CCL14 expression, tumor immunity, and prognosis in Hepatocellular Carcinoma (HCC) remain unclear. CCL14 expression and its influence on tumor prognosis were analyzed by th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Yurong, Li, Xiangyong, Bi, Yanhua, Zheng, Yubao, Wang, Jialiang, Li, Xiaoyan, Huang, Zexuan, Chen, Lubiao, Huang, Yanlin, Huang, Yuehua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977663/ https://www.ncbi.nlm.nih.gov/pubmed/31927532 http://dx.doi.org/10.18632/aging.102656

Ejemplares similares

Serum HBV pregenomic RNA is correlated with Th1/Th2 immunity in treatment‐naïve chronic hepatitis B patients
por: Gu, Yurong, et al.
Publicado: (2019)

Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B
por: Gu, Yurong, et al.
Publicado: (2020)

Prognostic roles of the transcriptional expression of exportins in hepatocellular carcinoma
por: Chen, Lubiao, et al.
Publicado: (2019)

Correlations between cytokines produced by T cells and clinical-virological characteristics in untreated chronic hepatitis B patients
por: Gu, Yurong, et al.
Publicado: (2019)

Serum HBV pregenomic RNA exhibited opposite associations with NK(dim) and NK(bright) cell immunity in treatment-naïve chronic hepatitis B patients
por: Gu, Yurong, et al.
Publicado: (2021)

GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis
por: Wu, Xiaojuan, et al.
Publicado: (2017)

Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment
por: Li, Xiaoyan, et al.
Publicado: (2017)

Expression and clinical significance of inhibitory receptor Leukocyte-associated immunoglobulin-like receptor-1 on peripheral blood T cells of chronic hepatitis B patients: A cross-sectional study
por: Gu, Yurong, et al.
Publicado: (2021)

An Immuno-Clinic score model for evaluating T cell immunity and predicting early antiviral therapy effectiveness in chronic hepatitis B
por: Gu, Yurong, et al.
Publicado: (2020)

Synergistic effect of farnesyl transferase inhibitor lonafarnib combined with chemotherapeutic agents against the growth of hepatocellular carcinoma cells
por: Wang, Jialiang, et al.
Publicado: (2017)

HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression
por: Chen, Lubiao, et al.
Publicado: (2016)

Soluble programmed death‐1 is a useful indicator for inflammatory and fibrosis severity in chronic hepatitis B
por: Zhou, Liang, et al.
Publicado: (2019)

Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment
por: Chen, Lubiao, et al.
Publicado: (2018)

Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma
por: Wang, Jialiang, et al.
Publicado: (2023)

Pan-Cancer Landscape of NEIL3 in Tumor Microenvironment: A Promising Predictor for Chemotherapy and Immunotherapy
por: Liao, Weixin, et al.
Publicado: (2022)

Comprehensive Analysis of ANLN in Human Tumors: A Prognostic Biomarker Associated with Cancer Immunity
por: Zhang, Xiaoyu, et al.
Publicado: (2022)

Activated Hepatic Stellate Cells Induce Infiltration and Formation of CD163(+) Macrophages via CCL2/CCR2 Pathway
por: Xi, Sujuan, et al.
Publicado: (2021)

CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma
por: Lin, Tong, et al.
Publicado: (2021)

The combination of lonafarnib and sorafenib induces cyclin D1 degradation via ATG3-mediated autophagic flux in hepatocellular carcinoma cells
por: Wang, Jialiang, et al.
Publicado: (2019)

Correction for: The combination of lonafarnib and sorafenib induces cyclin D1 degradation via ATG3-mediated autophagic flux in hepatocellular carcinoma cells
por: Wang, Jialiang, et al.
Publicado: (2019)

CKLF as a Prognostic Biomarker and Its Association with Immune Infiltration in Hepatocellular Carcinoma
por: Li, Dan, et al.
Publicado: (2023)

Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma
por: Huang, Yanlin, et al.
Publicado: (2018)

Overexpressing CCT6A Contributes To Cancer Cell Growth By Affecting The G1-To-S Phase Transition And Predicts A Negative Prognosis In Hepatocellular Carcinoma
por: Zeng, Guofen, et al.
Publicado: (2019)

Poor Prognostic Biomarker KIAA1522 Is Associated with Immune Infiltrates in Hepatocellular Carcinoma
por: Shi, Yongjie, et al.
Publicado: (2023)

Downregulated Trophinin-Associated Protein Plays a Critical Role in Human Hepatocellular Carcinoma Through Upregulation of Tumor Cell Growth and Migration
por: Lian, Yifan, et al.
Publicado: (2018)

Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Deng, Zenghua, et al.
Publicado: (2021)

MRGBP is a potential novel prognostic biomarker and is correlated with immune infiltrates in hepatocellular carcinoma
por: Huang, Juanjun, et al.
Publicado: (2021)

CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Luo, Jun-peng, et al.
Publicado: (2021)

Prognostic Role of ceRNA Network in Immune Infiltration of Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma
por: Su, Jinfang, et al.
Publicado: (2022)

Biejiajian Pill Promotes the Infiltration of CD8(+) T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5
por: Yang, Xuemei, et al.
Publicado: (2021)

Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma
por: Qi, Zhenhua, et al.
Publicado: (2020)

Tumor Secretion of CCL22 Activates Intratumoral Treg Infiltration and Is Independent Prognostic Predictor of Breast Cancer
por: Li, Ya-Qing, et al.
Publicado: (2013)

Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration
por: Nong, Ju‐sen, et al.
Publicado: (2023)

Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment
por: Chen, Bowen, et al.
Publicado: (2020)

G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
por: Wang, Hang, et al.
Publicado: (2022)

Dynamic Changes of Lipopolysaccharide Levels in Different Phases of Acute on Chronic Hepatitis B Liver Failure
por: Pan, Calvin, et al.
Publicado: (2012)

AGTRAP Is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Shanshan, et al.
Publicado: (2021)

Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma
por: Ning, Gang, et al.
Publicado: (2020)

KLF4 loss in hepatocellular carcinoma: Improving prognostic prediction and correlating immune infiltrates
por: Chen, Desheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2fi99ksh876vaec192onc2uh62